An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

August 21, 2024

Conditions
Prostate Cancer
Interventions
DEVICE

SpaceOAR Hydrogel

The SpaceOAR System is an in-situ formed absorbable hydrogel that is administered transperineally (with transrectal ultrasound guidance) between the prostate and rectum

Trial Locations (1)

030013

Shanxi Cancer Hospital, Taiyuan

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY